Companies · Software / Tech

NeuroTrack Technologies, Inc.

Redwood City · Software / Tech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on NeuroTrack Technologies, Inc. — recommendation, valuation, rhythm, risks.
$33.9M
Total raised · real
4
Rounds
2.1×
Latest step-up
Top 14%
Sector rank · raised
Series B
Latest stage · inferred · Thu May 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

NeuroTrack Technologies, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.17× the median modeled value of Series B Software / Tech companies in 2019–2021 (142 peers) — value vs value, same stage and era.
  • Within the normal band (117% of peer median) for its niche.
Dormant
  • Last raise 7.1 yr ago; this sector typically re-raises about every 13 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Software / Tech

NeuroTrack Technologies, Inc. is one of 3920 Software / Tech companies tracked from Redwood City. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2019-05-23
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeed · 2013-06-28 Raised $2.0M (real) Modeled valuation $68M (est)$2.0M$68MSeed2013Seed · 2014-12-05 Raised $1.0M (real) Modeled valuation $34M (est)$1.0M$34MSeed2014Series A · 2015-12-01 Raised $6.5M (real) Modeled valuation $180M (est)$6.5M$180MSeries A2015Series A · 2015-12-01 Raised $9.9M (real) Modeled valuation $273M (est)$9.9M$273MSeries A2015Series B · 2019-05-23 Raised $21M (real) Modeled valuation $641M (est)$21M$641MSeries B2019+$1.0M+$6.5M+$9.9M+$21MCumulative $40M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2013
Seed extension$1.0M · 2014
Series A$6.5M · 2015
Series A extension$9.9M · 2015
Series B$21.1M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$641.4M
Base estimate est.
$51.6M
Conservative case
$2.5B
Upside case
$117.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.

Seed · modeled $68.1M · 2013-06-282013Seed · modeled $34.1M · 2014-12-05Series A · modeled $180.3M · 2015-12-01Series A · modeled $273.5M · 2015-12-01Series B · modeled $641.4M · 2019-05-232019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
67%
Survival probability
44% low · 81% high
1.42×/yr
Annual markup
1.72×/yr upside case
6.0 yr
Elapsed time used
7.1 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
18 mo
Avg between rounds
$5.7M/yr
Capital velocity
13.0 yr
On record since
2013
First round
5
Rounds on file
How it compares to the market

Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.4× above median
This company$33.9M
Sector median$4.6M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.1× above median
This company$21.1M
Sector median$19.9M
Modeled value — vs sector median (estimate, all stages) 18× above median
This company$641.4M
Sector median$36.6M

Raised more than 87% of sector peers (real $). Modeled value above 93% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #49 of 142.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)Trackonomy Systems, Inc. · Series B Raised $49.2M · modeled $1.2B (est)Tray.IO Inc. · Series B Raised $59.3M · modeled $1.1B (est)Unravel Data Systems, Inc. · Series B Raised $56.2M · modeled $1.1B (est)Salus Labs, Inc. · Series B Raised $35.0M · modeled $1.1B (est)Anchor Labs, Inc. · Series B Raised $33.7M · modeled $1.0B (est)Compound Labs, Inc. · Series B Raised $41.8M · modeled $1.0B (est)Mode Analytics, Inc. · Series B Raised $72.3M · modeled $996.8M (est)Cleo Labs, Inc · Series B Raised $84.7M · modeled $958.4M (est)Bevy Labs, Inc. · Series B Raised $55.0M · modeled $956.5M (est)Temperpack Technologies Inc. · Series B Raised $79.9M · modeled $940.4M (est)Hound Labs, Inc. · Series B Raised $49.2M · modeled $933.9M (est)Cloud Elements, Inc. · Series B Raised $60.2M · modeled $913.7M (est)NeuroTrack Technologies, Inc. (this company) Raised $33.9M · modeled $641.4M (est)NeuroTrack Technologies, Inc.
CompanyStageRaised · realValue · estvs peer med.
Trackonomy Systems, Inc.Series B$49.2M$1.2B2.16×
Tray.IO Inc.Series B$59.3M$1.1B2.06×
Unravel Data Systems, Inc.Series B$56.2M$1.1B1.95×
Salus Labs, Inc.Series B$35.0M$1.1B1.95×
Anchor Labs, Inc.Series B$33.7M$1.0B1.88×
Compound Labs, Inc.Series B$41.8M$1.0B1.84×
Mode Analytics, Inc.Series B$72.3M$996.8M1.83×
Cleo Labs, IncSeries B$84.7M$958.4M1.76×
Bevy Labs, Inc.Series B$55.0M$956.5M1.75×
Temperpack Technologies Inc.Series B$79.9M$940.4M1.72×
Hound Labs, Inc.Series B$49.2M$933.9M1.71×
Cloud Elements, Inc.Series B$60.2M$913.7M1.67×
NeuroTrack Technologies, Inc. this companySeries B$33.9M$641.4M1.17×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2013-06-28$10.0M$68.1M85%
Seed$1.0M2014-12-05$5.0M$34.1M85%
Series A$6.5M2015-12-01$29.5M$180.3M85%
Series A$9.9M2015-12-01$44.8M$273.5M90%
Series B$21.1M2019-05-23$117.0M$641.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2013-06-28
    • First recorded raise — entered as Seed.
    • 13 investors on this round.
  2. Seed$1.0M2014-12-05
    • Raised 17 mo later, in step with the ~13 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Series A$6.5M2015-12-01
    • Raised 12 mo later, in step with the ~13 mo sector norm.
    • Round 6.5× larger than the prior — scaling up.
    • 10 investors on this round.
  4. Series A$9.9M2015-12-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 11 investors on this round.
  5. Series B$21.1M2019-05-23
    • Raised again after 42 mo — slower than the ~13 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~18mo cadence
$45.0M
Modeled next size est.range $29.2M$72.0M
2.1×
Last step-up
$5.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Samir Kaul31 other2015-12
CHERYL SCOTT1 other2019-05
Michael Johns1 other2014-12
Elli Kaplan2013-06
Phil Wickham2019-05
Registry & provenance

NeuroTrack Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1577569
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Z21 Labs, Inc.Software / TechSeries B$33.5M$775.1Msame sector · same stage
Uniform Systems, Inc.Software / TechSeries B$33.0M$620.8Msame sector · same stage
Logiwa Technology, Inc.Software / TechSeries B$34.9M$399.1Msame sector · same stage
Netronome Systems, Inc.Software / TechSeries B$35.1M$290.7Msame sector · same stage
Indico Data Solutions INCSoftware / TechSeries B$35.3M$583.4Msame sector · same stage
BET Information Systems, Inc.Software / TechSeries B$32.5M$367.8Msame sector · same stage
Umbra Lab, Inc.Software / TechSeries B$32.4M$884.2Msame sector · same stage
Usa Technologies IncSoftware / TechSeries B$35.5M$603.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
NeuroVasc Technologies, Inc.Software / TechSeries A$115.4M90%
NeuroRecovery Technologies, Inc.Software / TechSeed$103.5M89%
NeuroClear Technologies, Inc.Software / TechSeries A$298.2M87%
NeuroTronik, Inc.Other Health CareSeed$3.0M84%
Recuro Health, Inc.HealthtechSeries B$340.0M84%
Neurogami Medical, Inc.HealthtechSeries A$22.4M84%
Neuronetrix Solutions, LLCOther Health CareSeed$50.0M83%
Neograft Technologies, Inc.Software / TechSeries A$138.7M83%
Frequently asked
How much funding has NeuroTrack Technologies, Inc. raised?
NeuroTrack Technologies, Inc. has raised approximately $33.9M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is NeuroTrack Technologies, Inc.'s estimated valuation?
Provath's modeled valuation for NeuroTrack Technologies, Inc. is approximately $641.4M (modeled range $51.6M–$2.5B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NeuroTrack Technologies, Inc. at?
NeuroTrack Technologies, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Thu May 23.
What does NeuroTrack Technologies, Inc. do and where is it based?
NeuroTrack Technologies, Inc. operates in the Software / Tech sector, based in Redwood City.
Explore related

See where NeuroTrack Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NeuroTrack Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.